A-share innovative-drug sector opened sharply higher after Moderna jumped 177% overnight when it and Merck said a melanoma vaccine met the primary endpoint in a large trial. Hansen Pharma and Ha Sanlian posted second straight daily limit-ups. Haixin, Zhongguancun, Laimei Pharma, Watson Bio, Jiankai Technology, Shuanglu Pharma, Kangchen Pharma and Yuekang hit daily price limits. Sanyuan Gene rose >20%; Zhifei Bio and Shiyao Innovation gained >15%; Xinkaiyuan, Anke Biotech and Kangtai Biotech rall

A-share innovative-drug sector opened sharply higher after Moderna jumped 177% overnight when it and Merck said a melanoma vaccine met the primary endpoint in a large trial. Hansen Pharma and Ha Sanlian posted second straight daily limit-ups. Haixin, Zhongguancun, Laimei Pharma, Watson Bio, Jiankai Technology, Shuanglu Pharma, Kangchen Pharma and Yuekang hit daily price limits. Sanyuan Gene rose >20%; Zhifei Bio and Shiyao Innovation gained >15%; Xinkaiyuan, Anke Biotech and Kangtai Biotech rallied >10%.